Perbedaan MNC Asia Holding Tbk. dan Brigit Biofarmaka Teknologi Tbk.: MNC Asia Holding Tbk. diperdagangkan di Rp26 (kapitalisasi pasar 2,24 T, volume 24 jam 2,08 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp244 (kapitalisasi pasar 164,65 M, volume 24 jam 214,9 rb). Perbedaan utamanya: MNC Asia Holding Tbk. jauh lebih besar — sekitar 13,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan MNC Asia Holding Tbk. lebih aktif diperdagangkan (2,08 jt vs 214,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BHIT | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 2,24 T | 164,65 M |
Volume | 2,08 jt | 214,9 rb |
Lot | 20,82 rb | 2,15 rb |
Perputaran | 53,46 jt | 51,97 jt |
Harga Rata-rata | 25,68 | 241,85 |
Nilai Transaksi | 53,46 jt | 51,97 jt |
Harga Ekuilibrium Indikatif | 26 | 240 |
Volume Ekuilibrium Indikatif | 2,54 rb | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT MNC Investama Tbk formerly PT Bhakti Investama Tbk was established on 2 November, 1989 in Surabaya to engage in the capital market business and has fully developed itself into a full financial service business. In 1999, the Company has decided to shift its focus into an investment company. Through several corporate actions, such as restructuring, merger, acquisition and direct investment, the Company has positioned itself as a holding company of several subsidiaries, currently comprising of two strategic investments, namely Media through PT Global Mediacom Tbk and financial services through PT Bhakti Capital Indonesia Tbk. Aside from the two strategic investments, the Company also possesses several investment portfolios that offer attractive growth opportunities, such as PT Global Transport Services, PT Citra Marga Nusaphala Persada Tbk, PT MNC SkyVision and several other investment portfolios.
Selengkapnya di halaman BHIT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →